The recently advertised PhD and research associate roles have now closed but if you are interested in joining the Armstrong Group and want to discuss different options (self funded, scholarships, fellowships) then please contact email@example.com
James specializes in the development of technologies that can guide the assembly of biomaterials and engineered tissues. He received his PhD in Functional Nanomaterials from the University of Bristol, and conducted his postdoctoral studies at Imperial College under the guidance of Prof. Molly Stevens. His work has been funded by an Arthritis Research UK Foundation Fellowship (2015-2018), an MRC/UKRI Innovation Rutherford Fund Fellowship (2018-2021), and a UKRI Future Leaders Fellowship (2018-2025). In 2019, he was awarded a President’s Medal for Excellence in Education recognizing his pastoral care in student supervision.
Martha received her BSc in Biomedical Science from the University of Sheffield in 2020, during which she specialized in neurobiology and received the neuroscience prize upon graduation. Following this, she worked as a research assistant in the Wade-Martins group at the University of Oxford, using iPSC and CRISPRi technologies to study mitochondrial dysfunction in Parkinson’s disease, funded by an industry collaboration with BMS Celgene. She joined as a PhD candidate in the Armstrong Group in February 2022, and her project will apply her background in neuroscience and genetics to develop new strategies for brain organoid bioengineering.
Ximena received her BSc Hons in Genomic Biotechnology at Universidad Autónoma de Nuevo León in Monterrey, México in 2018; during which she conducted research on the development of smart therapeutics to combat antimicrobial resistance. In 2019, she joined the Bristol Centre of Functional Nanomaterials PhD programme on a project co-funded by the Mexican Science and Technology Research Council (CONACYT), the University of Bristol, and Cytoseek Ltd. Her primary supervisor is Prof. Adam Perriman and her project focuses on the generation of 3D bioprinted tumour models for the evaluation of novel immunotherapy approaches.
Sammy graduated in 2020 from the University of Sussex with a BSc in Computer Science, specialising in artificial intelligence and specifically reinforcement learning. In 2021, he graduated with an MSc in Artificial Intelligence from King’s College London, with a dissertation using Gaussian processes to predict a diagnosis of sepsis in intensive care units. He then joined the University of Bristol in September as a UKRI Digital Health and Care CDT student. He started his project in the Armstrong Group in June 2022, in which he is developing a machine learning pipeline for automated analysis of precision medicine candidates in ovarian cancer.
Norah-Jane holds a BSc. in Pharmacology from University College Dublin and a dual International Master’s Degree in Innovative Medicine from the University of Groningen and Uppsala University. She conducted her Master’s thesis project in the Ingber Lab at the Wyss Institute, Harvard University, where she focused on novel target discovery at the blood-brain barrier. She will join the Armstrong Group as a PhD candidate in October 2022, where she will work on a project to assemble an in vitro model of the blood-brain barrier using advanced bioprinting technologies, a collaborative project with Dr Liliang Ouyang at Tsinghua University, Beijing.
Yi Huang received his BEng in 2019 from Nanchang Hangkong University, in which his major was Flight Vehicle Manufacture Engineering. Then he graduated from Xiamen University with an MEng in Aeronautical Engineering in June 2022. During this period, he gained experience in 3D printing of glass, coating, and electrochemical machining. He will join the University of Bristol in October 2022 as a Mechanical Engineering PhD student funded by a Chinese Scholarship Council studentship. His primary supervisor is Dr. Fengyuan Liu and his project will involve the 3D/4D printing technology of bioresorbable coronary stents.
Camila graduated from the University of Sao Paulo (Brazil) in 2020 with a Ph.D. in Chemistry, conducting research in the fields of bone biomaterials and biomineralization. Since 2020, Camila has been working as a postdoctoral research fellow at Sorbonne Université, leading research into the pathological and physiological formation of bone. She will be joining as a Marie Skłodowska-Curie postdoctoral fellow in the Armstrong Group in February 2023, and her project will apply her background in collagen and biomineralization to develop a new regenerative therapy for the repair of non-union bone fractures.
Office 2.08, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY